Advertisement

Index by author

May 01, 1997; Volume 281,Issue 2

  1. Abbruscato, Thomas J.

    1. Structure-Activity Relationships of a Series of [d-Ala2]Deltorphin I and II Analogues;in Vitro Blood-Brain Barrier Permeability and Stability
      Sarah A. Thomas, Thomas J. Abbruscato, Vincent S. Hau, Terrence J. Gillespie, Joseph Zsigo, Victor J. Hruby and Thomas P. Davis
      Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 817-825;

  2. Abe, Ayat

    1. Effects of Adrenergic, Cholinergic and Ganglionic Blockade on Acute Depressor Responses to Metformin in Spontaneously Hypertensive Rats
      Martin S. Muntzel, Ayat Abe and Jørgen S. Petersen
      Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 618-623;

  3. Aguerre, Sylvie

    1. Central Serotonergic Systems in the Spontaneously Hypertensive and Lewis Rat Strains that Differ in the Elevated Plus-Maze Test of Anxiety
      Alexander Kulikov, Sylvie Aguerre, Olivier Berton, Andre Ramos, Pierre Mormede and Francis Chaouloff
      Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 775-784;

  4. Albuquerque, Edson X.

    1. Amantadine Inhibits Nicotinic Acetylcholine Receptor Function in Hippocampal Neurons
      Hiroaki Matsubayashi, Karen L. Swanson and Edson X. Albuquerque
      Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 834-844;

  5. Althaus, J. S.

    1. Pyrrolopyrimidines: Novel Brain-Penetrating Antioxidants with Neuroprotective Activity in Brain Injury and Ischemia Models
      E. D. Hall, P. K. Andrus, S. L. Smith, T. J. Fleck, H. M. Scherch, B. S. Lutzke, G. A. Sawada, J. S. Althaus, P. F. Vonvoigtlander, G. E. Padbury, P.G. Larson, J. R. Palmer and G. L. Bundy
      Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 895-904;

  6. Amin, Dilip

    1. RPR 107393, a Potent Squalene Synthase Inhibitor and Orally Effective Cholesterol-Lowering Agent: Comparison with Inhibitors of HMG-CoA Reductase
      Dilip Amin, Ruth Z. Rutledge, Saul N. Needle, Helen F. Galczenski, Kent Neuenschwander, Anthony C. Scotese, Martin P. Maguire, Ray C. Bush, Dave J. Hele, Glenda E. Bilder and Mark H. Perrone
      Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 746-752;

  7. Andonegui, Graciela

    1. Losartan, a Selective Inhibitor of Subtype AT1 Receptors for Angiotensin II, Inhibits the Binding ofN-Formylmethionyl-leucyl-phenylalanine to Neutrophil Receptors
      Silvina Raiden, Mirta Giordano, Graciela Andonegui, Analía S. Trevani, Daniel H. López, Victor Nahmod and Jorge R. Geffner
      Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 624-628;

  8. Andrus, P. K.

    1. Pyrrolopyrimidines: Novel Brain-Penetrating Antioxidants with Neuroprotective Activity in Brain Injury and Ischemia Models
      E. D. Hall, P. K. Andrus, S. L. Smith, T. J. Fleck, H. M. Scherch, B. S. Lutzke, G. A. Sawada, J. S. Althaus, P. F. Vonvoigtlander, G. E. Padbury, P.G. Larson, J. R. Palmer and G. L. Bundy
      Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 895-904;

  9. Askew, Ben C.

    1. Nonpeptide Glycoprotein IIb/IIIa Inhibitors. 15. Antithrombotic Efficacy of L-738,167, a Long-Acting GPIIb/IIIa Antagonist, Correlates with Inhibition of Adenosine Diphosphate-Induced Platelet Aggregation but not with Bleeding Time Prolongation
      Jacquelynn J. Cook, Gary R. Sitko, Marie A. Holahan, Maria T. Stranieri, Joan D. Glass, Ben C. Askew, Charles J. McIntyre, David A. Claremon, John J. Baldwin, George D. Hartman, Robert J. Gould and Joseph J. Lynch
      Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 677-689;

  10. Attucci, Sabina

    1. Pharmacological Characterization of 1-Aminoindan-1,5-dicarboxylic Acid, a Potent mGluR1 Antagonist
      Flavio Moroni, Grazia Lombardi, Christian Thomsen, Patrizia Leonardi, Sabina Attucci, Fiamma Peruginelli, Serenella Albani Torregrossa, Domenico E. Pellegrini-Giampietro, Roberto Luneia and Roberto Pellicciari
      Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 721-729;
« Previous (Pages : 1 2 3 4 5 6 ... 25) Next »
Back to top

In this issue

Advertisement